These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 1667978

  • 1. [Various properties of the Na+, K(+)-ATPase and the Mg (2+)-ATPase in erythrocytes from normotensive and hypertensive subjects].
    Canestrari F, Galli F, Gheller G, De Crescentini S, Biagiarelli B.
    Boll Soc Ital Biol Sper; 1991 Jul; 67(7):659-66. PubMed ID: 1667978
    [Abstract] [Full Text] [Related]

  • 2. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension.
    Fu Y, Wang S, Lu Z, Li H, Li S.
    Chin Med J (Engl); 1998 Feb; 111(2):147-9. PubMed ID: 10374376
    [Abstract] [Full Text] [Related]

  • 3. Alteration of erythrocyte membrane Na, K-ATPase in children with borderline or essential hypertension.
    Stojadinovic ND, Petronijević MR, Pavićević MH, Mrsulja BB, Kostić MM.
    Cell Biochem Funct; 1996 Jun; 14(2):79-87. PubMed ID: 8640956
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Erythrocyte membrane ouabain-sensitive Na+, K(+)-ATPase of hypertensive Nigerians.
    Olorunsogo OO, Lawal SO, Falase AO, Okunade WG.
    Afr J Med Med Sci; 1991 Jun; 20(2):75-82. PubMed ID: 1652190
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
    Maslova MN, Ogorodnikova LE, Titkov IuS.
    Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alteration in ouabain-sensitive sodium potassium pump of erythrocytes during pregnancy induced hypertension: a kinetic study.
    Kaur G, Kapoor N, Mohan P, Sri Nageswari K, Singh MJ, Prasad R.
    J Biochem Mol Biol Biophys; 2002 Jun; 6(3):163-6. PubMed ID: 12186749
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The (Ca2+, Mg2+)-ATPase activity in erythrocyte membranes from essential hypertensive patients.
    Gutiérrez A, Ariza R, Frati-Munari AC, Oliva G, Mas-Oliva J.
    Arch Invest Med (Mex); 1991 Jun; 22(3-4):279-83. PubMed ID: 1844113
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Abnormal erythrocyte Na, K-ATPase activity in a northeastern Thai population.
    Tosukhowong P, Chotikasatit C, Tungsanga K, Sriboonlue P, Prasongwattana V, Pansin P, Sitprija V.
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23(3):526-30. PubMed ID: 1336901
    [Abstract] [Full Text] [Related]

  • 14. Platelet and erythrocyte Mg2+, Ca2+, Na+, K+ and cell membrane adenosine triphosphatase activity in essential hypertension in blacks.
    Touyz RM, Milne FJ, Reinach SG.
    J Hypertens; 1992 Jun; 10(6):571-8. PubMed ID: 1320078
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.
    Zheng B, Oishi K, Shoji M, Eibl H, Berdel WE, Hajdu J, Vogler WR, Kuo JF.
    Cancer Res; 1990 May 15; 50(10):3025-31. PubMed ID: 2159369
    [Abstract] [Full Text] [Related]

  • 16. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
    Coughlin RT, Akera T, McGroarty EJ, Steinbach C.
    Mol Pharmacol; 1987 Jul 15; 32(1):147-53. PubMed ID: 3037299
    [Abstract] [Full Text] [Related]

  • 17. [Transmembrane Na+ transport kinetics in arterial hypertension: relations with vascular risk parameters].
    Caballero Oliver A, Stiefel García-Junco P, García-Donas López MA, Villar Ortiz J, Carneado de la Fuente J.
    Med Clin (Barc); 1995 Dec 08; 105(20):768-73. PubMed ID: 8558976
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of changes in dietary sodium intake on normotensive subjects with and without a genetic predisposition to essential hypertension.
    Weissberg PL, West MJ, Wilkins MR, Kricka LJ.
    J Hypertens Suppl; 1984 Dec 08; 2(3):S511-3. PubMed ID: 6100752
    [Abstract] [Full Text] [Related]

  • 20. [Effect of natriuretic hormone and changes in the lipid spectrum of erythrocyte membranes on the activity of enzymes of transmembrane ion transport in patients with essential hypertension].
    Gapon LI, Shafer MZh, Velizhanina IA, Zhuravleva TD.
    Ter Arkh; 1990 Dec 08; 62(12):40-4. PubMed ID: 1964748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.